These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 25417101)

  • 1. Camouflage and misdirection: the full-on assault of ebola virus disease.
    Misasi J; Sullivan NJ
    Cell; 2014 Oct; 159(3):477-86. PubMed ID: 25417101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune evasion in ebolavirus infections.
    Audet J; Kobinger GP
    Viral Immunol; 2015 Feb; 28(1):10-8. PubMed ID: 25396298
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Woolsey C; Borisevich V; Agans KN; Fenton KA; Cross RW; Geisbert TW
    mBio; 2021 Aug; 12(4):e0151721. PubMed ID: 34372693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological features underlying viral hemorrhagic fevers.
    Messaoudi I; Basler CF
    Curr Opin Immunol; 2015 Oct; 36():38-46. PubMed ID: 26163194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of ebolavirus glycoproteins in viral pathogenesis.
    Ning YJ; Deng F; Hu Z; Wang H
    Virol Sin; 2017 Feb; 32(1):3-15. PubMed ID: 27853993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Filoviral immune evasion mechanisms.
    Ramanan P; Shabman RS; Brown CS; Amarasinghe GK; Basler CF; Leung DW
    Viruses; 2011 Sep; 3(9):1634-49. PubMed ID: 21994800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of host immune responses in Ebola virus infections.
    Wong G; Kobinger GP; Qiu X
    Expert Rev Clin Immunol; 2014 Jun; 10(6):781-90. PubMed ID: 24742338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses.
    Wrensch F; Karsten CB; Gnirß K; Hoffmann M; Lu K; Takada A; Winkler M; Simmons G; Pöhlmann S
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S210-8. PubMed ID: 26034199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Ebola virus infection results in substantial immune activation.
    McElroy AK; Akondy RS; Davis CW; Ellebedy AH; Mehta AK; Kraft CS; Lyon GM; Ribner BS; Varkey J; Sidney J; Sette A; Campbell S; Ströher U; Damon I; Nichol ST; Spiropoulou CF; Ahmed R
    Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4719-24. PubMed ID: 25775592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins.
    Lázaro-Frías A; Gómez-Medina S; Sánchez-Sampedro L; Ljungberg K; Ustav M; Liljeström P; Muñoz-Fontela C; Esteban M; García-Arriaza J
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29514907
    [No Abstract]   [Full Text] [Related]  

  • 11. Ebola virus entry: a curious and complex series of events.
    Moller-Tank S; Maury W
    PLoS Pathog; 2015 Apr; 11(4):e1004731. PubMed ID: 25928849
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo Ebola virus infection leads to a strong innate response in circulating immune cells.
    Caballero IS; Honko AN; Gire SK; Winnicki SM; Melé M; Gerhardinger C; Lin AE; Rinn JL; Sabeti PC; Hensley LE; Connor JH
    BMC Genomics; 2016 Sep; 17(1):707. PubMed ID: 27595844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Exosomal VP40 in Ebola Virus Disease.
    Pleet ML; DeMarino C; Lepene B; Aman MJ; Kashanchi F
    DNA Cell Biol; 2017 Apr; 36(4):243-248. PubMed ID: 28177658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innate immune evasion by filoviruses.
    Basler CF
    Virology; 2015 May; 479-480():122-30. PubMed ID: 25843618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody Responses.
    Prescott J; Falzarano D; Feldmann H
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S271-6. PubMed ID: 25948862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serology and cytokine profiles in patients infected with the newly discovered Bundibugyo ebolavirus.
    Gupta M; MacNeil A; Reed ZD; Rollin PE; Spiropoulou CF
    Virology; 2012 Feb; 423(2):119-24. PubMed ID: 22197674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions.
    Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human transbodies that interfere with the functions of Ebola virus VP35 protein in genome replication and transcription and innate immune antagonism.
    Seesuay W; Jittavisutthikul S; Sae-Lim N; Sookrung N; Sakolvaree Y; Chaicumpa W
    Emerg Microbes Infect; 2018 Mar; 7(1):41. PubMed ID: 29568066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent immune responses after Ebola virus infection.
    Sobarzo A; Ochayon DE; Lutwama JJ; Balinandi S; Guttman O; Marks RS; Kuehne AI; Dye JM; Yavelsky V; Lewis EC; Lobel L
    N Engl J Med; 2013 Aug; 369(5):492-3. PubMed ID: 23902512
    [No Abstract]   [Full Text] [Related]  

  • 20. Host Factors Involved in Ebola Virus Replication.
    Rasmussen AL
    Curr Top Microbiol Immunol; 2018; 419():113-150. PubMed ID: 28710692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.